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Background: The Borderline Symptom List-23 (BSL-23) is a reliable and valid self-report instrument for assessing
Borderline Personality Disorder (BPD) severity. The psychometric properties of the original version have proven to
be adequate. The aim of the present study was to validate the Spanish language version of the BSL-23.
Methods: The BSL-23 was administered to 240 subjects with BPD diagnosis. Factor structure, reliability, test-retest
stability, convergent validity, and sensitivity to change were analyzed.
Results: The Spanish version of the BSL-23 replicates the one-factor structure of the original version. The scale has
high reliability (Cronbach’s alpha=.949), as well as good test-retest stability, which was checked in a subsample
(n=74; r=.734; p<.01). The Spanish BSL-23 shows moderate to high correlations with depressive symptomatology,
state and trait anxiety, hostility and impulsivity scores and BPD measures. The Spanish BSL-23 is able to discriminate
among different levels of BPD severity and shows satisfactory sensitivity to change after treatment, which was
verified by assessing change before and after 12 group sessions of Dialectical Behavioral Therapy in a subgroup of
31 subjects.
Conclusions: Similar to the original BSL-23, the Spanish BSL-23 is a reliable and valid instrument for assessing BPD
severity and sensitivity to change.
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Borderline Personality Disorder (BPD) is a severe psy-
chiatric condition affecting from 1 to 5.9% of the general
population [1,2]. However, in clinical populations, BPD
is prevalent in up to 25% of inpatients [3]. According to
the DSM-IV criteria [4], BPD is characterized by a per-
vasive pattern of instability in interpersonal relation-
ships, identity, impulsivity, and affect. BPD is associated
with high rates of suicide [5], comorbid Axis I and II
mental disorders [6-8], severe functional impairment [9],
and high costs for psychiatric services [9,10]. BPD diag-
nosis is generally based on (1) generic Axis II diagnostic
interviews that include all DSM-IV Axis II diagnoses such* Correspondence: jsolerri@santpau.cat
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reproduction in any medium, provided the oras the SCID-II [11] or (2) BPD-specific structured inter-
views such as the Diagnostic Interview for Borderlines-
Revised (DIB-R) [12,13], which improve the specificity
and accuracy of the diagnosis.
Due to the wide range of BPD symptoms, studies of
this disorder have used multiple symptomatology scales
designed to evaluate Axis I disorders. The use of several
different scales gives an indirect assessment of BPD
symptoms. However, more recently, several BPD-specific
scales based on DSM-IV criteria have been developed to
increase accuracy of the diagnosis and decrease the time
needed to perform the assessment. Clinician-administered
scales include the BPD Severity Index IV (BPDSI-IV) [14],
the Zanarini Rating Scale for Borderline Personality
Disorder (ZAN-BPD) [15], and the Clinical Global Im-
pression scale for BPD patients (CGI-BPD) [16]. Differ-
ences between these scales mainly involve administration
time, time-frame considered, and the number of items
used to assess each criterion. Despite the goodd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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instruments, they all have certain disadvantages, such as a
long administration time or a need for clinical expertise to
perform the assessments.
At the moment, only three self-reported scales are avail-
able to assess BPD severity. The Borderline Evaluation of
Severity Over Time (BEST) [17], a 15-item instrument
composed of 3 subscales to assess the thoughts, emotions,
and behaviours typical of BPD subjects and to measure se-
verity and changes in BPD. The second instrument is the
Borderline Symptom List (BSL-95), created by Bohus et al.
[18] based on DSM-IV criteria and the DIB-R, including
the collaboration of clinical experts and patients. The
BSL-95 contains 95 items to evaluate the subjective com-
plaints common among BPD subjects. Each item is quan-
titatively assessed on a 5-point Likert scale that ranges
from 0 (not at all) to 4 (very strong). The BSL-95 has
strong psychometric properties, but its length makes it
impractical in some settings. For this reason, the original
version (BSL-95) was later reduced to create the Border-
line Symptom List-23 (BSL-23) [19]. The BSL-23 includes
those items from the original version that had shown the
highest levels of sensitivity to change and that discriminate
best between BPD and other disorders. In addition, be-
cause the new version contains only 23 items, the admin-
istration time is considerably shortened. The psychometric
properties of the BSL-23 were assessed in 5 different BPD
patient samples. A total of 659 subjects were evaluated
and correlation between the BSL-95 and the BSL-23 was
high. The principal component analysis suggested a struc-
ture of one dominant factor. Findings showed a high in-
ternal consistency, high test-retest reliability, and good
sensitivity to change after Dialectical Behavioral Therapy
(DBT) treatment. In short, the authors considered that the
BSL-23 was a reliable and brief self-reported instrument
for assessing BPD severity as well as sensitivity to change.
Several instruments have been created to assess BPD
diagnosis and severity in the Spanish population [13,16].
However, no validated self-report measures are yet avail-
able to specifically assess BPD severity. For this reason,
the aim of the present study was to validate the Spanish
language version of the BSL-23 in a sample of subjects
with BPD diagnosis. The psychometric properties of
Spanish version of the BSL-23 and its sensitivity to
change due to therapeutic intervention were tested.
Method
Participants
The total sample consisted of 240 subjects recruited
from mental health settings in Spanish public institu-
tions. Sample size was considered appropriate taking
into account psychometric recommendations that sug-
gest 5 to 10 individuals per item [20]. Inclusion criteriaconsisted of BPD diagnosis according to DSM-IV criteria
as assessed by a structured interview (DIB-R) [13] and
age between 18 and 45 years. Exclusion criteria were as
follows: comorbidity with bipolar disorder, schizophrenia,
current major depressive disorder, substance dependence,
and severe difficulties in reading comprehension. All par-
ticipants had to be native Spanish speakers.
This study was approved by the Clinical Research Ethics
Committee at the Hospital de la Santa Creu i Sant Pau
and carried out in accordance with the Declaration of
Helsinki. Participants were given a detailed description of
the study and gave their written informed consent.
Instruments
Diagnosis interview
–Revised Diagnostic Interview for Borderlines (DIB-R)
[13]. The DIB-R is a structured interview for assessing
BPD diagnosis criteria in four areas: impulsive behavior,
cognitive area, affective area and interpersonal relation-
ships. The assessment focuses on the prior two years
and the scale ranges from 0 to 10, with a cut-off level set
at 6 for a diagnosis of BPD [13].
Scales
– Borderline Symptom List – 23 (BSL-23) [19]. The
BSL-23 is a self-rated scale that assesses BPD
symptomatology. The original version is composed
of a one-factor structure and has shown a high
internal consistency as evidenced by a Cronbach’s
alpha of 0.93. It has also shown good reliability for
BPD diagnosis as well as a satisfactory sensitivity to
change. Administration of the BSL-23 takes an
average of 3 to 4 minutes.
– Barrat Impulsivity Scale (BIS-11) [21]. The BIS-11 is
a 30-item self-reported scale that contains 3
subscales: motor impulsivity, cognitive impulsivity,
and lack of planning. The global impulsivity score
ranges between 0 and 120.
– Beck Depression Inventory (BDI-II) [22]. This self-
report instrument consists of 21 items to evaluate
depressive symptomatology.
– State Trait Anxiety Inventory (STAI) [23]. STAI is a
40-item questionnaire with two subscales (20 items
each), one to assess state anxiety (STAI-S) and the
other to evaluate trait anxiety (STAI-T). Total scores
range from 0 to 60, and there is no clinical cut-off in
the Spanish version.
– Buss-Durkee Hostility Inventory (BDHI) [24]. The
BDHI is a self-reported true/false questionnaire with
75 items, 7 subscales (Assault, Indirect Hostility,
Irritability, Negativism, Resentment, Suspicion, and
Verbal Hostility) and a global hostility score.
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[16]. The CGI-BPD assesses the severity of BPD
symptoms as well as sensitivity to therapeutic change.
This clinician-administered scale measures the
severity of nine items using a 7-point Likert scale. The
items are based on DSM-IV diagnosis criteria for
BPD. In our study, the CGI-BPD was only
administered to a sub-sample of patients to assess
sensitivity to change.
Procedure
Participants were enrolled in the study over a two-year
period according to the predetermined inclusion and
exclusion criteria. Subjects received information about
the study aims and instructions on how to complete the
tests. Participation in the study was voluntary and no fi-
nancial retribution was given.
The BSL-23 was translated from English to Spanish by
three native Spanish speakers with clinical expertise and
in accordance with the author’s supervision. An indepen-
dent native English-speaking translator with expertise in
translation of bio-medical texts translated this Spanish
version back into English. The authors of the original
BSL-23 version approved the final Spanish version.
To analyze the convergent validity of the Spanish
BSL-23, the following scales were used: BIS-11, BDI,
STAI-S, STAI-T, BDHI and CGI-BPD (this latter avail-
able only from 31 individuals). Correlation between
BSL-23 and DIB-R was also performed in order to as-
certain the convergence with a diagnostic instrument
for BPD. To study test-retest reliability of the Spanish
BSL-23, a sub-sample of 74 participants were asked
to complete the instrument again after one week. To
examine sensitivity to change following treatment, 31
individuals completed the BSL-23 before and after 3
months intervention based on DBT in a group format
(1 session per week). The DBT group therapy consists of
a skills training 2 hours per week. These skills are di-
vided into four modules: Interpersonal Effectiveness,
Emotion Regulation, Distress Tolerance and Mindful-
ness. This sub-sample also completed the CGI-BPD be-
fore and after treatment.
In order to test if BSL-23 was able to differentiate
among different levels of BPD severity, the following
procedure was used. A stepwise backward linear regres-
sion analysis was performed including BDI for affective
symptomatology, BIS-11 subscales for impulsivity, and
BDHI subscales for hostility and aggression as independent
variables to predict CGI-BPD scores as the dependent vari-
able. BDI total score, BIS-11 non-planning impulsivity and
all BDHI subscales except “Distrust” significantly predicted
CGI-BPD scores (R2=.73; p=.03). The unstandardized
values from the regression model were then divided into
quartiles, which served to finally classify participants infour categories of BPD severity. This variable was intro-
duced as between-group factor in a one-way ANOVA with
BSL-23 scores as the dependent variable.
Data analysis
Data analysis was carried out using SPSS 18.0 statistical
software for Windows. Descriptive statistics were used to
describe the demographic and clinical characteristics of
the sample. An exploratory factorial analysis (EFA) of
principal components with a Varimax rotation was per-
formed to examine the factorial structure of the scale. It
was used Confirmatory Factor Analysis (CFA) to explore
the goodness of fit of the original one-factor structure of
the BSL. EQS software for Windows version 6.1 [25] was
used to conduct the CFA. The maximum likelihood with
robust correction method was used to adjust for distribu-
tional problems in the data set. Although a model with a
non-significant chi-square estimate is generally considered
a model with good fit, Hu and Bentler [26] recommended
combinational rules to evaluate model fit. The following
criteria were used to indicate the fit of the CFA models to
the data: CFI (Comparative Fit Index) and GFI (Goodness
of Fit Index) >.90 and RMSEA (Root Mean Square Error
of Approximation) <.08. Values for CFI and GFI ranged
from 0 to 1. These fit statistics and the chi-square were se-
lected because previous research has demonstrated their
performance and stability [26,27].
To test internal consistency, global Cronbach’s alpha
was estimated and the split-half method was also ap-
plied. In addition, Cronbach’s alpha was estimated with
each of the 23 items removed one at a time from the
scale. Test-retest reliability and convergent validity were
evaluated by correlation analysis. In order to assess the
BSL-23 sensitivity to clinical change, we analyzed post-
minus pre- treatment scores using a t-test comparison.
Additionally, we compared this change value with CGI-
BPD results through correlational analysis.
Results
Socio-demographic and clinical characteristics of the
sample
As shown in Table 1, more than half of the sample were
women (57.5%), with a mean age of 32.4 years old (SD=8).
A slight majority were single (52.8%) and most had com-
pleted at least secondary schooling. Most subjects (80%)
were not working or studying at the time of the study.
BPD symptomatology was moderate to severe, and the
mean DIB-R score was 7.4 (SD=1.6).
Factor structure
The Kaiser-Meyer-Olkin (KMO) measure yielded a value
of .952 and Bartlett’s Test of Sphericity was significant
(p<.001). An initial exploratory component analysis with
a Varimax rotation showed a three factor structure with
Table 1 Socio-demographic and clinical characteristics of
the sample
BPD (n=240)
Age (M, SD) 32.4 (8)
DIB- R (M, SD) 7.4 (1.6)
Gender – Woman (%) 57.5
Marital status (%)
Single 52.8
Married 32.3
Divorced 14.5
Widow .4
Education (%)
No education 3.8
Primary school 34.6
Secondary education 44.2
University 15.4
Current activity (%)
Employed 16.7
Student 3.3
unemployed 80%
Note. BPD=Borderline Personality Disorder; DIB-R=Diagnostic Interview for
Borderlines Revised.
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accounting for 59.1% of total variance. The scree plot,
however, suggested a unifactorial solution (Figure 1). A
posterior EFA was performed by fixing one factor. The
unifactorial solution explained 48.11% of total variance.
Most of the items (22 out of 23) showed total factorialFigure 1 Scree plot of the BSL-23 Spanish version.loadings superior to .40, except for item 23. Table 2
shows the factorial loadings of each item.
The one-factor model in the CFA showed good fit
indices sbχ
2= 574.7904 (p<.001), (CFI= .905, GFI=.767,
SRMR=.053, RMSEA= .079 [.071-.087]). According to
the fit indices, the one-factor model represents correctly
the observed data.Reliability
The Cronbach’s alpha coefficient was .936 and the split-
half method yielded a correlation of r=.92, indicating that
the scale has a high overall internal consistency. In the
item-by-item reliability analysis, Cronbach's alpha coeffi-
cient showed a slight improvement (from .936 to .949) in
its value when item 23 was not included.
Analysis of test-retest stability within one week was
performed in a subsample of 74 subjects, with satisfactory
results (r=.734; p<.01).Convergent validity
As shown in Table 3, positive moderate to high correla-
tions were observed between the scores on the BSL-23 and
depression symptoms measured by the BDI (r=.787), state-
anxiety measured by the STAI-S (r=.705), trait-anxiety by
means of STAI-T (r=.746), hostility measured by the BDHI
(r=.421) and impulsivity measured by the BIS (r=.376). All
correlations were highly significant at p< .001. Correlation
analyses between BSL-23 and DIB-R and CGI-BPD showed
that this latter was strongly associated with BSL-23, while
DIB-R was moderately related (see Table 3).
Table 2 Factor Structure of the BSL-23 Spanish version
BSL Items Factor 1
BSL-1 Me resultaba difícil concentrarme .702
BSL-2 Me sentí indefenso .737
BSL-3 Estuve ausente e incapaz de recordar
que estaba haciendo en realidad
.606
BSL-4 Sentí asco .569
BSL-5 Pensé en hacerme daño .767
BSL-6 Desconfié de los demás .586
BSL-7 No creía que tuviera derecho a vivir .775
BSL-8 Me sentía solo .749
BSL-9 Sentí una tensión interna estresante .800
BSL-10 Sentí mucho miedo de imágenes
que me vinieron a la cabeza
.655
BSL-11 Me odié a mí mismo .825
BSL-12 Quise castigarme .603
BSL-13 Sufrí de vergüenza .640
BSL-14 Mi humor oscilaba rápidamente entre
la ansiedad, la rabia y la depresión
.831
BSL-15 Sufrí al oír voces y ruidos procedentes
de dentro o fuera de mi cabeza
.521
BSL-16 Las críticas tuvieron un efecto demoledor
en mí
.711
BSL-17 Me sentí vulnerable .752
BSL-18 La idea de morirme me causó una
cierta fascinación
.782
BSL-19 Nada parecía tener sentido para mí .839
BSL-20 Tuve miedo de perder el control .797
BSL-21 Me di asco a mí mismo .600
BSL-22 Tuve la sensación de salir de mí mismo .490
BSL-23 Sentí que no valía nada .373
Table 3 Correlations between Spanish version of BSL-23
scores and other scales
BSL-23
Beck Depression Inventory (BDI) .787**
State Trait Anxiety Inventory – S (STAI-S) .705**
State Trait Anxiety Inventory – T (STAI-T) .746**
Buss-Durkee Hostility Inventory (BDHI) Total Score .421**
BDHI – Fisical Hostility .200**
BDHI – Verbal Hostility .244**
BDHI- Indirect Hostility .373**
BDHI - Irritability .396**
BDHI - Resentment .412**
BDHI - Distrust .333**
BDHI - Negativism .180*
BDHI - Guilt .301**
Barrat Impulsivness Scale (BIS) – Total Score .376**
BIS – Attentional .144*
BIS - Motor .424**
BIS - Nonplanning .276**
CGI-BPD .889**
DIB-R .407**
*p<.05, **p<.001.
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To establish the scale’s ability to detect improvement
in BPD symptomatology, the delta scores (difference
between the first and second administration scores)
obtained in BSL-23 were correlated with the improve-
ment observed in the CGI-BPD (measured before and
after a 3-month DBT skills training treatment) in a sub
sample of 31 patients with BPD. The mean pre- and
post-treatment scores for the BSL-23 were, respectively,
2.21 (SD=.96), and 1.83 (SD=.96; p= .01). For the CGI-
BPD, the mean pre- and post-treatment scores were 4.80
(SD=1.04) and 4.16 (SD= .96.; p= .002), respectively. The
mean change was obtained for both the BSL-23 and the
CGI-BPD (including overall score plus all subscales) in
order to compare pre- and post-treatment scores. The
correlation between the mean change in BSL-23 and in
the CGI-BPD global score was significant (r=.79). Other
significant correlations were identified for the followingsubscales: Abandonment (r=.636), Unstable Relationships
(r=.719), Impulsivity (r=.675), Suicide(r=.733), Affective
Instability (r=.836), Anger (r=.810) and Paranoid Idea-
tion (r=.503). All reported correlations were significant
at p<.01.
Discrimination among BPD severity levels
BSL-23 was able to discriminate among different levels
of BPD severity [F(3,179)=51.18; p<.001]. Table 4 dis-
plays Bonferroni’s posthoc analyses regarding BSL-23
scores among groups. As it can be observed BSL-23 dif-
ferentiated all groups of severity.
Discussion
Although BPD is the most commonly studied personality
disorder in clinical trials, only a very limited number of
self-reported questionnaires are available to specifically
assess BPD severity and sensitivity to change following
therapeutic interventions. Moreover, none of the existing
instruments had been adapted for Spanish speakers, until
now. The original BSL-95 was shortened to the BSL-23 to
reduce assessment time and to target sensitivity to change.
In the current study, the Spanish BSL-23 has shown good
psychometric properties similar to the original version.
The principal component analysis of the current ins-
trument presents a unidimensional factor structure identi-
cal to the original version. The percentage of variance
Table 4 BSL mean scores’ distribution by BPD severity levels as measured by the categorical CGI-BPD unstandardized
scores
1st quartile
(n=46)
2nd quartile
(n=46)
3rd quartile
(n=46)
4th quartile
(n=45)
Bonferroni posthoc comparisons
BSL-23 scores .55 [.61] 1.03 [.81] 1.78 [.81] 2.44 [.89] (1st )<(2nd)*,
(1st )< (3rd)***, (1st )< (4th)***,
(2nd)<(3rd )***, (2nd)< (4th)***,
(3rd)<(4th)**
*p<.05; **p<.01; ***p<.001.
Mean and SD (between brackets) are represented. The following quartile values represent each severity level according to predicted CGI-BPD scores: 1st quartile:
3.59, 2nd quartile: 4.27; 3rd quartile: 4.9; 4th quartile: 6.63. BPD: Borderline Personality Disorder,.
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the one obtained in the original validation study [18]. In
our study, this unidimensional model was also confirmed
by a CFA. The findings show a high internal consistency
of the Spanish short version of BSL as indicated by the
high Cronbach’s alpha and Spearman-Brown coefficient.
Although item 23 shows less psychometric robustness
compared to the rest on factorial and reliability ana-
lyses, their psychometric indexes range from moderate
to acceptable values. Moreover, the reliability of the
Spanish BSL-23 is similar to that of the English versions
(BSL-23 and BSL-95), both of which had a Cronbach’s
alpha of .97.
The one-week temporal reliability of the scale was high
(r=.73) and comparable to the scores obtained in the ori-
ginal BSL-23 (r=.82) and BSL-95 (r=.84) studies [18,19].
Given the wide spectrum of symptoms for BPD, we
expected to observe positive correlations between the
Spanish version of BSL-23 and other self-reported scales
designed to assess depression and anxiety symptoms,
hostility, and impulsivity. BSL-23 scores showed a posi-
tive correlation with BDI, BDHI, BIS and STAI-S and
STAI-T and this correlation ranged from low/moderate
–BDHI and BSI (r=.144 to r=.424; including subscales)–
to high: BDI and STAI subscales (r=.705 to r=.787). The
original BSL-23 study showed a strong correlation be-
tween scores on affective symptomatology and BSL-23
[19]; in our study, we also found a high correlation be-
tween BSL-23 and BDI scores. This association between
depressive symptomatology and BPD scales has also
been reported in other self-reported BPD scales [17].
However, unlike the original study by Bohus et al. [19],
we found high and significant correlations between anx-
iety symptoms and BSL-23. Although measures of hos-
tility and impulsivity were not used to study convergent
validity in previous BSL validations, we found moderate
and positive correlations between Spanish BSL-23 and
BDHI (hostility) and BIS (impulsivity) scores. The corre-
lations seen in our study were similar to those previously
described by Bohus et al. [18]. As expected, correlationsbetween BSL-23 and other specific BPD instruments i.e.
DIB-R and CGI-BPD indicating good and excellent con-
vergent validity, respectively. The slight discrepancy of
convergent validity with regard these two instruments
may be due to the fact that BSL-23 and CGI-BPD assess
the same temporal frame (one week), while the DIB-R
recalls information for the last two years. These results
support the convergent validity of the Spanish version of
the questionnaire and the capacity of the BSL-23 to dif-
ferentiate different levels of severity is a strong attribute
of the scale to be used either in clinical settings and
research.
The instrument also showed a good capacity to detect
changes produced by therapeutic BPD interventions. To
assess sensitivity to changes, we carried out a 3-month
DBT group therapy program whose effectiveness in BPD
patients had been proven in a previous study [28]. This
therapeutic intervention, based on self-regulatory skills
acquisition, was nearly identical to the program used in
the original BSL-23 [19]. In our study, BSL-23 scores
were compared to the CGI-BPD [16], an instrument also
developed to assess changes in BPD symptoms after
treatment, and we found a strong positive correlation
between both instruments. BSL-23 also correlate posi-
tively (r≥.50) with improvements observed in the CGI-
BPD subscales for Abandonment, Unstable Relationships,
Impulsivity, Suicide, Affective Instability, Anger Paranoid
Ideation.
Finally, a limitation of our study is the absence of a
non-BPD clinical group comparison as had been done in
the original English version with five different psychiatric
samples [19].Conclusions
To conclude, the Spanish BSL-23 is a reliable instrument
for assessing and discriminating BPD severity and clinical
outcomes after a psychotherapeutic intervention. More-
over, administration-time is brief and it is suitable for use
in both research and clinical settings.
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